Author:
Brehme Marc,Koschmieder Steffen,Montazeri Maryam,Copland Mhairi,Oehler Vivian G.,Radich Jerald P.,Brümmendorf Tim H.,Schuppert Andreas
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Wong, S. & Witte, O. N. The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 22, 247–306 (2004).
2. Van Etten, R. A. Oncogenic signaling: new insights and controversies from chronic myeloid leukemia. J. Exp. Med. 204, 461–465 (2007).
3. Brehme, M. et al. Charting the molecular network of the drug target Bcr-Abl. Proc. Natl. Acad. Sci. USA 106, 7414–7419 (2009).
4. Fausel, C. Targeted chronic myeloid leukemia therapy: seeking a cure. J. Manag. Care Pharm. JMCP 13, 8–12 (2007).
5. Quintás-Cardama, A. & Cortes, J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113, 1619–1630 (2009).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献